Latest total liabilities for VPHIF: $95M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Valeo Pharma posts a total liabilities of $95M as of July 2024. That compares with $81M in the prior-year period — up 18.2% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Valeo Pharma's total liabilities was $81M. The latest reading is $95M — a 18.2% year-over-year increase (period ending July 2024). Use the history and growth charts on this page for a longer lookback.
Total Liabilities is one piece of Valeo Pharma's financial statement story. At $95M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for VPHIF's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Valeo Pharma's other metric pages and overview cover the third.